Sector outperformer, Torrent Pharmaceuticals, has delivered 1-year returns of 16. It has another 14% upside, says this brokerage. Company’s PAT rose 16% YoY while its revenue increased 9% over the corresponding quarter of the last financial year.
Buy Sun Pharma at Rs 1,805 | Target: Rs 1,968 | Upside: 9%
Sun Pharmaceutical Industries’ 12-month returns stand at near 3%. Company’s PAT rose 3% YoY while its revenue increased 9% over Q2FY25.
(Disclaimer: The recommendations, suggestions, views, and opinions given by the experts are their own. These do not represent the views of The Economic Times.)